久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • MediWound Announces NexoBrid BLA Acceptance for Severe Thermal Burns americanpharmaceuticalreview
    September 23, 2020
    MediWound announced the U.S. Food and Drug Administration (FDA) has accepted for review its recently submitted Biologics License Application (BLA) for NexoBrid? for eschar removal (debridement) in adults with deep partial-thickness and/or full-thickness..
  • MediWound Submits BLA Severe Thermal Burn Treatment americanpharmaceuticalreview
    July 10, 2020
    MediWound has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking the approval of NexoBrid? for eschar removal (debridement) in adults with deep partial-thickness and/or full-thickness thermal burns.
PharmaSources Customer Service